Loading…
S. 3314119th CongressIn committeeLatest action Dec 2, 2025Decoded by AI · checked against the record
The plain-language version leads. The official text is always the reference.
Senate bill S 3314 would extend VA's existing opioid written-consent rule to antipsychotics, stimulants, antidepressants, anti-anxiety drugs, and narcotics.
45-second read · 4 questions answered below
S 3314 would require VA doctors to explain the risks and benefits in writing and obtain a veteran's signed consent before prescribing antipsychotics, stimulants, antidepressants, anti-anxiety medications, or narcotics. This expands an existing written-consent rule that currently applies only to long-term opioid pain treatment. Veterans already taking any of these medications may also need to complete updated consent forms depending on how the VA implements the rule.
The bill directly affects veterans who receive healthcare through the VA system and the VA doctors and staff who treat them. It does not apply to private doctors or non-VA healthcare settings.
The medications added to the consent requirement can carry significant side effects or long-term consequences. Requiring written informed consent before prescribing these drugs would place new procedural obligations on VA clinical staff.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Veterans' Affairs.